Effectiveness and cost-effectiveness of different immunization strategies against whooping cough to reduce child morbidity and mortality

Health Policy

Volumn 115, Issue 1, 2014, Pages 82-91

  Rivero Santana, Amado ^a,b,c   Cuéllar Pompa, Leticia ^a,b,c   Sánchez Gómez, Luis M ^b,d,e   Perestelo Pérez, Lilisbeth ^a,b,c,f   Serrano Aguilar, Pedro ^a,b,c,f  

^a Canary Islands Foundation of Health and Research (FUNCIS)   (Spain)

^b Health Services Research on Chronic Patients Network (REDISSEC)   (Spain)

^c Center for Biomedical Research of the Canary Islands (CIBICAN)   (Spain)

^d C/ Diego León ^*  (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^f Evaluation Unit of the Canary Islands Health Service SESCS   (Spain)

Author keywords

Adolescent; Adult; Diphtheria tetanus pertussis vaccine; Health personnel; Immunization; Whooping cough

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; CHILD; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH CARE POLICY; HUMAN; MORTALITY; PREGNANCY; PROGRAM EVALUATION; WHOOPING COUGH;

ADOLESCENT; ADULT; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HEALTH POLICY; HUMANS; PERTUSSIS VACCINE; PREGNANCY; PROGRAM EVALUATION; WHOOPING COUGH;

EID: 84894374578     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2013.12.007     Document Type: Review

References (63)

1. Tan T., Trindade E., Skowronski D. Epidemiology of pertussis. Pediatric Infectious Disease Journal 2005, 24(Suppl. 5):10-18.
2. Wendelboe A.M., Hudgens M.G., Poole C., Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerging Themes in Epidemiology 2007, 4:15.
3. Bisgard K.M., Pascual F.B., Ehresmann K.R., Miller C.A., Cianfrini C., Jennings C.E., et al. Infant pertussis: who was the source?. Pediatric Infectious Disease Journal 2004, 11:985-989.
4. Wendelboe A.M., Njamkepo E., Bourillon A., Floret D.D., Gaudelus J., Gerber M., et al. Transmission of Bordetella pertussis to young infants. Pediatric Infectious Disease Journal 2007, 26:293-299.
5. Forsyth K.D., Wirsing von Konig C.H., Tan T., Caro J., Plotkin S. Prevention of pertussis: recommendations derived from the Second Global Pertussis Initiative Roundtable Meeting. Vaccine 2007, 25:2634-2642.
6. Cherry J.D. Epidemic pertussis in 2012: the resurgence of a vaccine-preventable disease. New England Journal of Medicine 2012, 367:785-787.
7. EUVAC-NET Group Pertussis surveillance report 2010 2013, Available at: http://www.ecdc.europa.eu/en/publications/Publications/pertussis_report_ 2010_euvacnet.pdf [accessed 12.01.13].
8. Situación de la tos ferina en España Red Nacional de Vigilancia Epidemiológica de España 2009, Ministerio de Ciencia e Innovación. Ministerio de Sanidad y Política Social.
9. Instituto de Salud Carlos III Enfermedades de declaración obligatoria-series temporales 2012, Available at: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnic os/fd-vigilancias-alertas/fd-enfermedades/enfermedades-declaracion-oblig atoria-series-temporales.shtml; Boletines semanales. Available at: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnic os/fd-vigilancias-alertas/fd-boletines/fd-boletin-epidemiologico-semanal -red/semanas-anteriores.shtml [accessed 05.12.12].
10. Mooi F.R. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infection, Genetics and Evolution 2010, 10:36-49.
11. Zhang L., Prietsch S.O., Axelsson I., Halperin S.A. Acellular vaccines for preventing whooping cough in children. Cochrane Database of Systematic Reviews 2011, 1. CD001478.
12. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatric Infectious Disease Journal 2005, 24(Suppl. 5):58-61.
13. Lavine J.S., Bjørnstad O.N., de Blasio B.F., Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 2012, 11(30):544-551.
14. Witt M.A., Katz P.H., Witt D.J. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clinical Infectious Diseases 2012, 54:1730-1735.
15. Center for Disease Control and Prevention Summary Report, June 22-23, 2011 2011, Available at: http://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-jun1 1.pdf [accessed 26.11.12].
16. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP). MMWR 2011, 41:1424-1426.
17. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR 2011, 60:13-15.
18. Centers for Disease Control and Prevention Immunization of health-care personnel. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2011, 7.
19. Joint Committee on Vaccination and Immunisation Minute of teleconference on Thursday, Wednesday 30 August 2012 10.00am-12.00am and post-teleconference discussion 2012, Available at: http://transparency.dh.gov.uk/2012/09/28/jcvi-pertussis/ [accessed 18.12.12].
20. European Centers for Disease Prevention and Control Scientific panel on childhood immunisation schedule: Diphtheria-tetanus-pertussis (DTP) vaccination 2009, Available at: http://ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.a spx?ID=458 [accessed 18.12.12].
21. OMS. Weekly epidemiological record. 1st October 2010, 85th year, No. 40, 2010;85:385-400.
22. Moreno-Pérez D., Alvarez García F.J., Aristegui Fernández J., Barrio Corrales F., Cilleruelo Ortega M.J., Corretger Rauet J.M., et al. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2012. Anales de Pediatría (Barc) 2011.
23. Scottish Intercollegiate Guidelines Network A guideline developers' handbook (publication no. 50) 2001, SIGN, Edinburgh.
24. Cochrane Effective Practice and Organisation of Care Review Group Data collection checklist 2012, Available at: http://epoc.cochrane.org/cochrane-resources-0 [accessed 18.12.12].
25. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926. for the GRADE Working Group.
26. Balshema H., Helfand M., Schünemann H.J., Oxman A.D., Kunz R., Brozek J., et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011, 64:401-406.
27. López-Bastida J., Oliva J., Antoñanzas F., García-Altés A., Gisbert R., Mar J., et al. Spanish recommendations on economic evaluation of health technologies. European Journal of Health Economics 2010, 11:513-520.
28. *Skoff T.H., Cohn A.C., Clark T.A., Messonnier N.E., Martin S.W. Early impact of the US Tdap vaccination program on pertussis trends. Archives of Pediatric and Adolescent Medicine 2012, 166:344-349.
29. *Quinn H.E., McIntyre P.B. The impact of adolescent pertussis immunization. Bulletin of the World Health Organization 2011, 89:666-674.
30. *Stein-Zamir C., Shoob H., Abramson N., Zentner G. The impact of additional pertussis vaccine doses on disease incidence in children and infants. Vaccine 2011, 29:207-211.
31. *Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. American Journal of Obstetrics and Gynecology 2011, 204(334):e1-e5.
32. *Leuridan E., Hens N., Peeters N., de Witte L., Van der Meeren O., Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatric Infectious Disease Journal 2011, 30:608-610.
33. Hardy-Fairbanks A.J., Pan S.J., Johnson D.R., Bernstein H.H. Immune responses in infants following receipt of pertussis immunization by their mothers during pregnancy. Presented at the 48th Infectious Diseases Society of America Annual Meeting 2010.
34. *Talbot E.A., Brown K.H., Kirkland K.B., Baughman A.L., A Halperin S., Broder K.R. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine 2010, 28:8001-8007.
35. *Zheteyeva Y.A., Moro P.L., Tepper N.K., Rasmussen S.A., Barash F.E., Revsina N.V., et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. American Journal of Obstetrics and Gynecology 2012, 207:59.e1-59.e7.
36. Wang M., Khromava A., Mahmood A., Dickson N. Pregnant women receiving tetanus-diphtheria-acellular pertussis (Tdap) vaccine: 6 years of adacel vaccine pregnancy registry data. Pharmacoepidemiology and Drug Safety 2011, 20:S60-S61.
37. *Castagnini L.A., Healy C.M., Rench M.A., Wootton S.H., Munoz F.M., Baker C.J. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clinical Infectious Diseases 2012, 54:78-84.
38. Winter K., Harriman K., Schechter R., Chang J., Talarico J. Effectiveness of postpartum Tdap vaccination in California hospitals, CSTE 2010.
39. *De Vries R., Kretzschmar M., Schellekens J.F.P., Versteegh F.G., Westra T.A., Roord J.J., et al. Cost-effectiveness of adolescent pertussis vaccination for The Netherlands: using an individual-based dynamic model. PLoS ONE 2010, 5:e13392.
40. *Caro J.J., Getsios D., El-Hadi W., Payne K., O'Brien J.A. Pertussis immunization of adolescents in the US: an economic evaluation. Pediatric Infectious Disease Journal 2005, 24(5):75-82.
41. *Lee G.M., LeBaron C.W., Murphy T.V., Lett S., Schauer S., Lieu T.A. Pertussis in adolescents and adults: should we vaccinate?. Pediatrics 2005, 115:1675-1684.
42. *Coudeville L., Van Rie A., Getsios D., Caro J.J., Crépey P., Nguyen V.H. Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects. PLoS ONE 2009, 4:e6284.
43. *Iskedjian M., Walker J.H., Hemels M.E. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada. Vaccine 2004, 22:4215-4227.
44. *Iskedjian M., Walker J.H., De Serres G., Einarson T.R. Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada. Paediatric Drugs 2005, 7:123-136.
45. *Edmunds W.J., Brisson M., Melegaro A., Gay N.J. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine 2002, 20:1316-1330.
46. *Lee G., Riffelmannd M., Von Konig C. Cost-effectiveness of adult pertussis vaccination in Germany. Vaccine 2008, 26:3673-3679.
47. *Westra T.A., De Vries R., Tamminga J.J., Sauboin C.J., Postma M.J. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clinical Therapeutics 2010, 32:1479-1495.
48. *Schuffham P.A., McIntyre P.B. Pertussis vaccination strategies for neonates - an exploratory cost-effectiveness analysis. Vaccine 2004, 22:2953-2964.
49. *Purdy K.W., Hay J.W., Botteman M.F., Ward J.I. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clinical Infectious Diseases 2004, 39:20-28.
50. *Hay J.W., Ward J.I. Economic considerations for pertussis booster vaccination in adolescents. Pediatric Infectious Disease Journal 2005, 24(Suppl. 6):127-133.
51. *Lee G.M., Murphy T.V., Lett S., Cortese M.M., Kretsinger K., Schauer S., et al. Cost effectiveness of pertussis vaccination in adults. American Journal of Preventive Medicine 2007, 32:186-193.
52. *de Greeff S.C., Lugnér A.K., van den Heuvel D.M., Mooi F.R., de Melker H.E. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies. Vaccine 2009, 27:1932-1937.
53. *Girard D.Z. The distribution over time of costs and social net benefits for pertussis immunization programs. International Journal of Health Care Finance and Economics 2010, 10:1-27.
54. *Greer A.L., Fisman D.N. Use of models to identify cost-effective interventions: pertussis vaccination for pediatric health care workers. Pediatrics 2011, 128:e591.
55. *Rozenbaum M.H., De Cao E., Postma M.J. Cost-effectiveness of pertussis booster vaccination in the Netherlands. Vaccine 2012, 30:7327-7331.
56. *Calugar A., Ortega-Sánchez I.R., Tiwari T., Oakes L., Jahre J.A., Murphy T.V. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clinical Infectious Diseases 2006, 42:981-988.
57. Englund J.A., Anderson E.L., Reed G.F., et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995, 96:580-584.
58. Van Savage J., Decker M.D., Edwards K.M., Sell S.H., Karzon D.T. Natural history of pertussis antibody in the infant and effect on vaccine response. Journal of Infectious Diseases 1990, 161:487-492.
59. Dalhousie University Pertussis maternal immunization study 2013, Identifier: NCT00553228. Available at: http://clinicaltrials.gov/show/nct00553228 [accessed 26.02.13].
60. National Institute of Allergy and Infectious Diseases Pertussis vaccine in healthy pregnant women 2013, Identifier: NCT00707148. Available at: http://clinicaltrials.gov/show/nct00707148 [accessed 26.02.13].
61. Healy C.M., Rench M.A., Baker C.J. Implementation of cocooning against pertussis in a high-risk population. Clinical Infectious Diseases 2011, 52:157-162.
62. Wicker S., Rose M.A. Health care workers and pertussis: an underestimated issue. Medizinische Klinik (Munich) 2010, 105:882-886.
63. Hope K., Butler M., Massey P.D., Cashman P., Durrheim D.N., Stephenson J., et al. Pertussis vaccination in child care workers: room for improvement in coverage, policy and practice. BMC Pediatrics 2012, 12:98.